{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:57:32Z","timestamp":1779303452092,"version":"3.51.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiomes"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive form of pancreatic cancer, with overall 5-year survival rates of about 8%. Obesity (and underlying metabolic dysfunction) is estimated to account for up to 50% of all PDACs. Microbial communities can be modulated by obesity and exert biological effects on tissues they colonize as well as distant sites.  Recent studies showed that tumors, including PDAC, harbor a microbiome that is able to regulate cancer outcomes such as tumor progression, response to therapy and overall survival. Yet, it is not understood whether patient\u2019s characteristics impact this relationship.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We examined the influence of obesity (defined by body weight in mice or body mass index [BMI] in humans) on the normal and cancerous pancreas microbiome in mice and humans using 16S sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, we observed that diet-induced obesity accelerated PDAC progression in the KC mouse model of PDAC. We also detected an obesity-induced decrease in the microbial abundance of the normal or cancerous pancreas. Obesity modified the bacterial community composition in the normal pancreas and PDAC of both mice and humans. Further, obese animals and humans each had a distinctive pancreatic microbiome signature with specific bacterial phylum, genus and species compared to controls. Notably, both the normal mouse pancreas and human PDAC showed an obesity-induced decrease in Pseudomonadota phylum. We also found that the presence of cancer by itself reduced microbial diversity in both the pancreas as well the intestinal microbiota. This reduction in microbial richness was further exacerbated by obesity. Finally, we observed that obesity increased inflammatory cytokines and altered the tumor immune infiltrate in humans and mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Further investigation of obesity-driven microbial differences in the pancreas could provide important insights for personalized treatments for PDAC patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frmbi.2025.1543144","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T05:31:06Z","timestamp":1753680666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Obesity reprograms the normal pancreas and pancreatic cancer microbiome in mice and humans"],"prefix":"10.3389","volume":"4","author":[{"given":"Raquel Santana","family":"da Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shravanthy","family":"Suguru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara P. C.","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ijeoma","family":"Nwugwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"de Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/1940-6207.CAPR-24-0055","article-title":"Diet modulates the gut microbiome, metabolism, and mammary gland inflammation to influence breast cancer risk","volume":"17","author":"Arnone","year":"2024","journal-title":"Cancer Prev. Res. (Phila)."},{"key":"B2","volume-title":"American cancer society cancer facts & Figures 2024","year":"2024"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","article-title":"A revised classification system and recommendations from the baltimore consensus meeting for neoplastic precursor lesions in the pancreas","volume":"39","author":"Basturk","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/mc.20778","article-title":"Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms","volume":"51","author":"Bracci","year":"2012","journal-title":"Mol. Carcinog."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1038\/s41467-018-07305-8","article-title":"Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression","volume":"9","author":"Calcinotto","year":"2018","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0184455","DOI":"10.1371\/journal.pone.0184455","article-title":"Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice","volume":"12","author":"Chang","year":"2017","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e2306776121","DOI":"10.1073\/pnas.2306776121","article-title":"A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation","volume":"121","author":"Chen","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0016","article-title":"Parental obesity programs pancreatic cancer development in offspring","volume":"26","author":"da Cruz","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jand.2017.07.005","article-title":"Diabetes mellitus and obesity as risk factors for pancreatic cancer","volume":"118","author":"Eibl","year":"2018","journal-title":"J. Acad. Nutr. Diet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/gutjnl-2016-312580","article-title":"Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study","volume":"67","author":"Fan","year":"2018","journal-title":"Gut."},{"key":"B11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/gutjnl-2011-300784","article-title":"Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer","volume":"61","author":"Farrell","year":"2012","journal-title":"Gut."},{"key":"B12","article-title":"Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over:United States, 1960\u20131962 through 2017\u20132018","author":"Fryar CD","year":"2020","journal-title":"NCHS Health E-Stats"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1093\/annonc\/mdv355","article-title":"Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies","volume":"26","author":"Genkinger","year":"2015","journal-title":"Ann. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.3748\/wjg.v28.i32.4698","article-title":"International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis","volume":"28","author":"Ilic","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-15-1177","article-title":"Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy","volume":"6","author":"Incio","year":"2016","journal-title":"Cancer Discov."},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11912-016-0528-7","article-title":"The gut microbiome and obesity","volume":"18","author":"John","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cgh.2012.11.016","article-title":"Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia","volume":"11","author":"Kanda","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2096328","DOI":"10.1080\/19490976.2022.2096328","article-title":"Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC","volume":"14","author":"Kesh","year":"2022","journal-title":"Gut Microbes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2079814","DOI":"10.1080\/20002297.2022.2079814","article-title":"Prevotella species as oral residents and infectious agents with potential impact on systemic conditions","volume":"14","author":"Kononen","year":"2022","journal-title":"J. Oral. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.798763","article-title":"Oral prevotella species and their connection to events of clinical relevance in gastrointestinal and respiratory tracts","volume":"12","author":"Kononen","year":"2021","journal-title":"Front. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/imm.2017.151.issue-4","article-title":"The immune response to Prevotella bacteria in chronic inflammatory disease","volume":"151","author":"Larsen","year":"2017","journal-title":"Immunology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1001\/jama.2009.886","article-title":"Body mass index and risk, age of onset, and survival in patients with pancreatic cancer","volume":"301","author":"Li","year":"2009","journal-title":"JAMA."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850093","article-title":"The interplay between inflammation and stromal components in pancreatic cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","article-title":"Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity","volume":"7","author":"Loo","year":"2017","journal-title":"Cancer Discov."},{"key":"B26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134318","article-title":"Modifiable pancreatic ductal adenocarcinoma (PDAC) risk factors","volume":"12","author":"Michalak","year":"2023","journal-title":"J. Clin. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jama.286.8.921","article-title":"Physical activity, obesity, height, and the risk of pancreatic cancer","volume":"286","author":"Michaud","year":"2001","journal-title":"JAMA."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3748\/wjg.v12.i19.3038","article-title":"Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients","volume":"12","author":"Nilsson","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3945\/cdn.117.001362","article-title":"Childhood body mass index and risk of adult pancreatic cancer","volume":"1","author":"Nogueira","year":"2017","journal-title":"Curr. Dev. Nutr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1440-1746.2011.07013.x","article-title":"Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell","author":"Pandol","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.semcancer.2025.05.004","article-title":"The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC","volume":"113","author":"Peduzzi","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41467-024-47359-5","article-title":"Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk","volume":"15","author":"Piening","year":"2024","journal-title":"Nat. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell."},{"key":"B37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10555-022-10022-w","article-title":"Connecting the human microbiome and pancreatic cancer","volume":"41","author":"Sexton","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061284","article-title":"Obesity and pancreatic cancer: recent progress in epidemiology, mechanisms and bariatric surgery","volume":"10","author":"Shinoda","year":"2022","journal-title":"Biomedicines."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1158\/0008-5472.CAN-20-2983","article-title":"Diet alters entero-mammary signaling to regulate the breast microbiome and tumorigenesis","volume":"81","author":"Soto-Pantoja","year":"2021","journal-title":"Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1002\/cam4.v12.5","article-title":"Role of microbiota and microbiota-derived short-chain fatty acids in PDAC","volume":"12","author":"Temel","year":"2023","journal-title":"Cancer Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0187552","DOI":"10.1371\/journal.pone.0187552","article-title":"The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre\/+;LSL-KrasG12D\/+ transgenic mouse model of pancreatic cancer","volume":"12","author":"Veite-Schmahl","year":"2017","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.semcancer.2023.07.004","article-title":"Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data","volume":"95","author":"Vick","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology."}],"container-title":["Frontiers in Microbiomes"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frmbi.2025.1543144\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T05:31:08Z","timestamp":1753680668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frmbi.2025.1543144\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":44,"alternative-id":["10.3389\/frmbi.2025.1543144"],"URL":"https:\/\/doi.org\/10.3389\/frmbi.2025.1543144","relation":{},"ISSN":["2813-4338"],"issn-type":[{"value":"2813-4338","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"article-number":"1543144"}}